GRPEL2 Human (1->4)-beta-D-glucan multiple interactions ISO RGD:1617618 6480464 [perfluorooctane sulfonic acid co-treated with Cellulose] results in decreased expression of GRPEL2 mRNA CTD PMID:36331819 GRPEL2 Human 17alpha-ethynylestradiol increases expression ISO RGD:1617618 6480464 Ethinyl Estradiol results in increased expression of GRPEL2 mRNA CTD PMID:17942748 GRPEL2 Human 17beta-estradiol increases expression EXP 6480464 Estradiol results in increased expression of GRPEL2 mRNA CTD PMID:19167446 GRPEL2 Human 17beta-estradiol decreases expression ISO RGD:1617618 6480464 Estradiol results in decreased expression of GRPEL2 mRNA CTD PMID:39298647 GRPEL2 Human 2,3,7,8-tetrachlorodibenzodioxine affects expression ISO RGD:1617618 6480464 Tetrachlorodibenzodioxin affects the expression of GRPEL2 mRNA CTD PMID:20702594 GRPEL2 Human 2,3,7,8-tetrachlorodibenzodioxine decreases expression ISO RGD:1585231 6480464 Tetrachlorodibenzodioxin results in decreased expression of GRPEL2 mRNA CTD PMID:32109520 GRPEL2 Human 2,3,7,8-tetrachlorodibenzodioxine increases expression ISO RGD:1617618 6480464 Tetrachlorodibenzodioxin results in increased expression of GRPEL2 mRNA CTD PMID:15328365|PMID:25975270|PMID:26290441 GRPEL2 Human 2,3,7,8-tetrachlorodibenzodioxine decreases expression EXP 6480464 Tetrachlorodibenzodioxin results in decreased expression of GRPEL2 mRNA CTD PMID:20106945|PMID:21632981 GRPEL2 Human 2,3,7,8-tetrachlorodibenzodioxine multiple interactions ISO RGD:1617618 6480464 [Tetrachlorodibenzodioxin co-treated with Lipopolysaccharides] results in decreased methylation of GRPEL2 gene; [TIPARP gene mutant form more ... CTD PMID:21212295|PMID:25975270 GRPEL2 Human 2,3,7,8-Tetrachlorodibenzofuran affects expression ISO RGD:1617618 6480464 2,3,7,8-tetrachlorodibenzofuran affects the expression of GRPEL2 mRNA CTD PMID:20702594 GRPEL2 Human 2-hydroxypropanoic acid increases expression EXP 6480464 Lactic Acid results in increased expression of GRPEL2 mRNA CTD PMID:30851411 GRPEL2 Human 4,4'-sulfonyldiphenol decreases expression ISO RGD:1617618 6480464 bisphenol S results in decreased expression of GRPEL2 mRNA CTD PMID:39298647 GRPEL2 Human 6-propyl-2-thiouracil decreases expression ISO RGD:1585231 6480464 Propylthiouracil results in decreased expression of GRPEL2 mRNA CTD PMID:30047161 GRPEL2 Human acetamide decreases expression ISO RGD:1585231 6480464 acetamide results in decreased expression of GRPEL2 mRNA CTD PMID:31881176 GRPEL2 Human acrylamide decreases expression ISO RGD:1585231 6480464 Acrylamide results in decreased expression of GRPEL2 mRNA CTD PMID:28959563 GRPEL2 Human acrylamide increases expression EXP 6480464 Acrylamide results in increased expression of GRPEL2 mRNA CTD PMID:32763439 GRPEL2 Human aflatoxin B1 increases expression ISO RGD:1617618 6480464 Aflatoxin B1 results in increased expression of GRPEL2 mRNA CTD PMID:19770486 GRPEL2 Human aflatoxin B1 increases methylation EXP 6480464 Aflatoxin B1 results in increased methylation of GRPEL2 gene CTD PMID:27153756 GRPEL2 Human all-trans-retinoic acid decreases expression EXP 6480464 Tretinoin results in decreased expression of GRPEL2 mRNA CTD PMID:33167477 GRPEL2 Human antirheumatic drug increases expression EXP 6480464 Antirheumatic Agents results in increased expression of GRPEL2 mRNA CTD PMID:24449571 GRPEL2 Human arsenite(3-) multiple interactions EXP 6480464 arsenite inhibits the reaction [G3BP1 protein binds to GRPEL2 mRNA] CTD PMID:32406909 GRPEL2 Human atrazine decreases expression EXP 6480464 Atrazine results in decreased expression of GRPEL2 mRNA CTD PMID:22378314 GRPEL2 Human benzo[a]pyrene increases expression ISO RGD:1617618 6480464 Benzo(a)pyrene results in increased expression of GRPEL2 mRNA CTD PMID:19770486 GRPEL2 Human benzo[a]pyrene increases expression EXP 6480464 Benzo(a)pyrene results in increased expression of GRPEL2 mRNA CTD PMID:20064835|PMID:22316170|PMID:26238291 GRPEL2 Human benzo[a]pyrene diol epoxide I increases expression EXP 6480464 7,8-Dihydro-7,8-dihydroxybenzo(a)pyrene 9,10-oxide results in increased expression of GRPEL2 mRNA CTD PMID:19150397|PMID:26238291 GRPEL2 Human beta-lapachone increases expression EXP 6480464 beta-lapachone results in increased expression of GRPEL2 mRNA CTD PMID:38218311 GRPEL2 Human bis(2-ethylhexyl) phthalate increases expression ISO RGD:1617618 6480464 Diethylhexyl Phthalate results in increased expression of GRPEL2 mRNA CTD PMID:21318169|PMID:34319233 GRPEL2 Human bis(2-ethylhexyl) phthalate increases expression EXP 6480464 Diethylhexyl Phthalate results in increased expression of GRPEL2 protein CTD PMID:31163220 GRPEL2 Human bisphenol A increases expression ISO RGD:1585231 6480464 bisphenol A results in increased expression of GRPEL2 mRNA CTD PMID:25181051|PMID:34947998 GRPEL2 Human carbon nanotube increases expression ISO RGD:1617618 6480464 Nanotubes, Carbon analog results in increased expression of GRPEL2 mRNA CTD PMID:25620056 GRPEL2 Human CGP 52608 multiple interactions EXP 6480464 CGP 52608 promotes the reaction [RORA protein binds to GRPEL2 gene] CTD PMID:28238834 GRPEL2 Human chloropicrin affects expression EXP 6480464 chloropicrin affects the expression of GRPEL2 mRNA CTD PMID:26352163 GRPEL2 Human ciguatoxin CTX1B affects expression ISO RGD:1617618 6480464 Ciguatoxins affects the expression of GRPEL2 mRNA CTD PMID:18353800 GRPEL2 Human cisplatin increases expression EXP 6480464 Cisplatin results in increased expression of GRPEL2 mRNA CTD PMID:27594783 GRPEL2 Human clofibrate increases expression ISO RGD:1617618 6480464 Clofibrate results in increased expression of GRPEL2 mRNA CTD PMID:23811191 GRPEL2 Human copper(II) sulfate increases expression EXP 6480464 Copper Sulfate results in increased expression of GRPEL2 mRNA CTD PMID:19549813 GRPEL2 Human dichloroacetic acid increases expression ISO RGD:1617618 6480464 Dichloroacetic Acid results in increased expression of GRPEL2 mRNA CTD PMID:28962523 GRPEL2 Human diquat decreases expression ISO RGD:1617618 6480464 Diquat results in decreased expression of GRPEL2 protein CTD PMID:36851058 GRPEL2 Human doxorubicin decreases expression EXP 6480464 Doxorubicin results in decreased expression of GRPEL2 mRNA CTD PMID:29803840 GRPEL2 Human enzyme inhibitor multiple interactions EXP 6480464 [Enzyme Inhibitors results in decreased activity of OGA protein] which results in increased O-linked glycosylation more ... CTD PMID:23301498 GRPEL2 Human fenofibrate increases expression ISO RGD:1617618 6480464 Fenofibrate results in increased expression of GRPEL2 mRNA CTD PMID:21318169 GRPEL2 Human fenofibrate multiple interactions ISO RGD:1617618 6480464 PPARA protein affects the reaction [Fenofibrate results in increased expression of GRPEL2 mRNA] CTD PMID:21318169 GRPEL2 Human flutamide increases expression ISO RGD:1617618 6480464 Flutamide analog results in increased expression of GRPEL2 mRNA; Flutamide results in increased expression of more ... CTD PMID:17702527 GRPEL2 Human hydrogen peroxide affects expression EXP 6480464 Hydrogen Peroxide affects the expression of GRPEL2 mRNA CTD PMID:20044591 GRPEL2 Human inulin multiple interactions ISO RGD:1617618 6480464 [perfluorooctane sulfonic acid co-treated with Inulin] results in decreased expression of GRPEL2 mRNA CTD PMID:36331819 GRPEL2 Human leflunomide increases expression EXP 6480464 leflunomide results in increased expression of GRPEL2 mRNA CTD PMID:28988120|PMID:29427785 GRPEL2 Human lipopolysaccharide multiple interactions ISO RGD:1617618 6480464 [Tetrachlorodibenzodioxin co-treated with Lipopolysaccharides] results in decreased methylation of GRPEL2 gene CTD PMID:21212295 GRPEL2 Human N-methyl-4-phenylpyridinium increases expression EXP 6480464 1-Methyl-4-phenylpyridinium results in increased expression of GRPEL2 mRNA CTD PMID:24810058 GRPEL2 Human N-methylformamide increases expression ISO RGD:1617618 6480464 methylformamide analog results in increased expression of GRPEL2 mRNA; methylformamide results in increased expression of more ... CTD PMID:17040096 GRPEL2 Human oxaliplatin decreases expression ISO RGD:1585231 6480464 oxaliplatin results in decreased expression of GRPEL2 mRNA CTD PMID:25729387 GRPEL2 Human oxaliplatin multiple interactions ISO RGD:1585231 6480464 [oxaliplatin co-treated with Topotecan] results in decreased expression of GRPEL2 mRNA CTD PMID:25729387 GRPEL2 Human paracetamol decreases expression EXP 6480464 Acetaminophen results in decreased expression of GRPEL2 mRNA CTD PMID:25704631 GRPEL2 Human perfluorooctane-1-sulfonic acid multiple interactions ISO RGD:1617618 6480464 [perfluorooctane sulfonic acid co-treated with Cellulose] results in decreased expression of GRPEL2 mRNA; [perfluorooctane sulfonic more ... CTD PMID:36331819 GRPEL2 Human perfluorooctanoic acid increases expression ISO RGD:1617618 6480464 perfluorooctanoic acid results in increased expression of GRPEL2 mRNA CTD PMID:21318169 GRPEL2 Human perfluorooctanoic acid increases expression EXP 6480464 perfluorooctanoic acid results in increased expression of GRPEL2 protein CTD PMID:26879310 GRPEL2 Human perfluorooctanoic acid multiple interactions ISO RGD:1617618 6480464 PPARA protein affects the reaction [perfluorooctanoic acid results in increased expression of GRPEL2 mRNA] CTD PMID:21318169 GRPEL2 Human phenobarbital multiple interactions ISO RGD:1617618 6480464 NR1I3 protein affects the reaction [Phenobarbital results in increased expression of GRPEL2 mRNA] CTD PMID:19482888 GRPEL2 Human phenobarbital affects expression ISO RGD:1617618 6480464 Phenobarbital affects the expression of GRPEL2 mRNA CTD PMID:23091169 GRPEL2 Human phenobarbital affects expression EXP 6480464 Phenobarbital affects the expression of GRPEL2 mRNA CTD PMID:19159669 GRPEL2 Human phenobarbital increases expression ISO RGD:1617618 6480464 Phenobarbital results in increased expression of GRPEL2 mRNA CTD PMID:19482888 GRPEL2 Human pirinixic acid multiple interactions ISO RGD:1617618 6480464 [pirinixic acid binds to and results in increased activity of PPARA protein] which results in more ... CTD PMID:19710929|PMID:21318169 GRPEL2 Human pirinixic acid increases expression ISO RGD:1617618 6480464 pirinixic acid results in increased expression of GRPEL2 mRNA CTD PMID:15375163|PMID:17426115|PMID:18301758|PMID:21318169|PMID:23811191 GRPEL2 Human pregnenolone 16alpha-carbonitrile decreases expression ISO RGD:1617618 6480464 Pregnenolone Carbonitrile results in decreased expression of GRPEL2 mRNA CTD PMID:28903501 GRPEL2 Human propiconazole decreases expression ISO RGD:1617618 6480464 propiconazole results in decreased expression of GRPEL2 mRNA CTD PMID:21278054 GRPEL2 Human rac-lactic acid increases expression EXP 6480464 Lactic Acid results in increased expression of GRPEL2 mRNA CTD PMID:30851411 GRPEL2 Human resveratrol increases expression ISO RGD:1617618 6480464 resveratrol results in increased expression of GRPEL2 protein CTD PMID:25505154 GRPEL2 Human rotenone increases expression ISO RGD:1617618 6480464 Rotenone results in increased expression of GRPEL2 mRNA CTD PMID:17702527 GRPEL2 Human sodium arsenite increases expression EXP 6480464 sodium arsenite results in increased expression of GRPEL2 mRNA CTD PMID:38568856 GRPEL2 Human sunitinib increases expression EXP 6480464 Sunitinib results in increased expression of GRPEL2 mRNA CTD PMID:31533062 GRPEL2 Human tetrachloroethene increases expression ISO RGD:1617618 6480464 Tetrachloroethylene results in increased expression of GRPEL2 mRNA CTD PMID:28973375 GRPEL2 Human tetrachloromethane decreases expression ISO RGD:1617618 6480464 Carbon Tetrachloride results in decreased expression of GRPEL2 mRNA CTD PMID:31919559 GRPEL2 Human thapsigargin increases expression EXP 6480464 Thapsigargin results in increased expression of GRPEL2 mRNA CTD PMID:22378314 GRPEL2 Human topotecan multiple interactions ISO RGD:1585231 6480464 [oxaliplatin co-treated with Topotecan] results in decreased expression of GRPEL2 mRNA CTD PMID:25729387 GRPEL2 Human triphenyl phosphate affects expression EXP 6480464 triphenyl phosphate affects the expression of GRPEL2 mRNA CTD PMID:37042841 GRPEL2 Human triticonazole increases expression ISO RGD:1585231 6480464 triticonazole results in increased expression of GRPEL2 mRNA CTD PMID:36084822 GRPEL2 Human tunicamycin increases expression EXP 6480464 Tunicamycin results in increased expression of GRPEL2 mRNA CTD PMID:22378314 GRPEL2 Human urethane increases expression EXP 6480464 Urethane results in increased expression of GRPEL2 mRNA CTD PMID:28818685 GRPEL2 Human valdecoxib increases expression ISO RGD:1585231 6480464 valdecoxib results in increased expression of GRPEL2 mRNA CTD PMID:24136188 GRPEL2 Human valproic acid decreases expression EXP 6480464 Valproic Acid results in decreased expression of GRPEL2 mRNA CTD PMID:23179753